FY2025 · period end Dec '25 · from the 10-K filed Mar 13, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.40B | $0.43B | $0.48B | $0.54B | $0.49B |
| Gross Profit | $0.23B | $0.25B | $0.28B | $0.31B | $0.29B |
| Operating Income | negative: -$0.11B | $0.00B | $0.01B | $0.03B | $0.04B |
| Net Income | negative: -$0.12B | negative: -$0.01B | $0.00B | $0.02B | $0.02B |
| EPS (Diluted) | negative: -$6.28 | negative: -$0.30 | $0.16 | $1.14 | $1.28 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.40B | $0.50B | $0.56B | $0.61B | $0.68B |
| Total Liabilities | $0.28B | $0.27B | $0.32B | $0.39B | $0.48B |
| Stockholders' Equity | $0.13B | $0.23B | $0.24B | $0.22B | $0.20B |
| Cash & Equivalents | $0.06B | $0.06B | $0.07B | $0.10B | $0.12B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.02B | negative: -$0.00B | $0.02B | $0.04B | $0.11B |
| Capital Expenditures | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| Free Cash Flow | $0.02B | negative: -$0.01B | $0.02B | $0.03B | $0.10B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 57.0% | 57.8% | 57.5% | 58.4% | 59.2% |
| Operating Margin | negative: -0.3% | negative: -0.0% | 0.0% | 0.1% | 0.1% |
| Net Margin | negative: -0.3% | negative: -0.0% | 0.0% | 0.0% | 0.1% |
| Return on Equity | negative: -67.0% | negative: -2.4% | 1.3% | 10.2% | 12.8% |
| Return on Assets | negative: -26.3% | negative: -1.1% | 0.5% | 3.4% | 3.8% |
| Debt / Equity | 0.28× | 0.15× | 0.15× | 0.23× | 0.37× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001193125-26-336932 | Jun 30, 2026 | Aug 6, 2026 | Aug 6, 2026 12:52 UTC | EDGAR |
| 8-K | 0001193125-26-326088 | Jul 30, 2026 | Jul 30, 2026 | Jul 30, 2026 20:02 UTC | EDGAR |
| 8-K | 0001193125-26-221590 | May 12, 2026 | May 13, 2026 | May 13, 2026 20:05 UTC | EDGAR |
| 10-Q | 0001193125-26-213464 | Mar 31, 2026 | May 8, 2026 | May 8, 2026 13:04 UTC | EDGAR |
| 8-K | 0001193125-26-208920 | May 6, 2026 | May 6, 2026 | May 6, 2026 20:05 UTC | EDGAR |
| 10-K | 0001193125-26-105114 | Dec 31, 2025 | Mar 13, 2026 | Mar 13, 2026 12:42 UTC | EDGAR |
| 8-K | 0001193125-26-048685 | Feb 12, 2026 | Feb 12, 2026 | Feb 12, 2026 21:05 UTC | EDGAR |
| 8-K | 0001193125-26-042776 | Feb 9, 2026 | Feb 9, 2026 | Feb 9, 2026 21:05 UTC | EDGAR |
Direct links to SEC EDGAR. FORR has additional filings available on the SEC site.
6 numbers FORRESTER RESEARCH, INC. later changed — same XBRL tag, both filings linked.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q2 2013
Major restatementwas$9.2M
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q2 2013
Major restatementwas$5.6M
Revised up in a 10-K. Any P/E built on the original was 9.1% too high.
Net Cash Provided by (Used in) Operating Activities·Q3 2013
Notable restatementwas$32.4M
Revised up in a 10-K. Any P/OCF built on the original was 8.5% too high.
Operating Income (Loss)·Q2 2013
Notable restatementwas$9M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q1 2013
Notable restatementwas$3.7M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2013
Notable restatementwas$3.7M
Revised down in a 10-Q.
FORR is not the only one.
See every restatement we've found across the market — or get an alert the next time FORR revises a number.
Restatements are detected by comparing every vintage of a fact across all of FORRESTER RESEARCH, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows FORR's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling FORRESTER RESEARCH, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on FORR yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on FORR and publish the result to your public profile.
Ask about FORRESTER RESEARCH, INC.
Continue in Workspace — cited answers on FORR, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs